Chemical Structure : YX-2-107
Catalog No.: PC-73342Not For Human Use, Lab Use Only.
YX-2-107 is a CRBN-recruiting and specific CDK6-degrading PROTAC with IC50 of 0.69 and 4.4 nM for CDK4 and CDK6 in vitro, selectively degardes CDK6 in Ph+ BV173 ALL cells with a degradation constant of 4 nM.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
YX-2-107 is a CRBN-recruiting and specific CDK6-degrading PROTAC with IC50 of 0.69 and 4.4 nM for CDK4 and CDK6 in vitro, selectively degardes CDK6 in Ph+ BV173 ALL cells with a degradation constant of 4 nM.
YX-2-107 does not affect expression of IKZF1 and IKZF3, and does not degarde CDK4 protein.
YX-2-107 inhibits S-phase entry, cell proliferation, RB phosphorylation, and FOXM1 expression and induces the selective degradation of CDK6 in Ph+ BV173 and SUP-B15 cells.|
PROTAC YX-2-107 is bioavailable in mice and pharmacologically active in suppressing Ph+ ALL proliferation in a mouse xenograft of Ph+ ALL, comparable or superior to that of the CDK4/6 enzymatic inhibitor palbociclib.
M.Wt | 889.971 | |
Formula | C45H51N11O9 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Marco De Dominici, et al. Blood. 2020 Apr 30;135(18):1560-1573.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright